Buy this Article for $3.95

Have a coupon or promotional code? Enter it here:

When you buy this you'll get access to the ePub version, a downloadable PDF, and the ability to print the full article.

Authors

  1. Aschenbrenner, Diane S. MS, RN

Abstract

* Injectable brodalumab (Siliq), a human monoclonal antibody that inhibits the release of inflammatory cytokines and chemokines, has been approved to treat moderate-to-severe plaque psoriasis.

 

* Because brodalumab may increase the risk of suicidal ideation and behavior, it is only available for those in the Food and Drug Administration's Risk Evaluation and Mitigation Strategy program.